5F-AKB48: Difference between revisions

>Josikins
>Josikins
Line 4: Line 4:


==Pharmacology==
==Pharmacology==
Although this substance has not been formally studied from analysis of the structure, it is presumed that AB-FUBINACA has a similar binding profile to that of other [[cannibanoids]] and matches many of the in vivo properties of [[Δ9-THC]]. As with the compounds within [[cannabis]], AB-FUBINACA exhibits its range of effects via full [[agonism]] of both the [[Cannabinoid#Cannabinoid_receptor_type_1|CB1]] and [[Cannabinoid#Cannabinoid_receptor_type_2|CB2]] [[cannabinoid]] [[receptors]], with some selectivity for CB2.
Although this substance has not been formally studied from analysis of the structure, it is presumed that 5F-AKB-48AB-FUBINACA has a similar binding profile to that of other [[cannibanoids]] and matches many of the in vivo properties of [[Δ9-THC]]. As with the compounds within [[cannabis]], 5F-AKB-48 exhibits its range of effects via full [[agonism]] of both the [[Cannabinoid#Cannabinoid_receptor_type_1|CB1]] and [[Cannabinoid#Cannabinoid_receptor_type_2|CB2]] [[cannabinoid]] [[receptors]], with some selectivity for CB2.


==Subjective effects==
==Subjective effects==